Lysine: N 6 -Hydroxylase: Stability and Interaction with Ligands by Marrone, Laura et al.
Journal of Protein Chemistry, Vol. 18, No. 8, 1999
Lysine: N6-Hydroxylase: Stability and Interaction
with Ligands
Scott Dick,1 Laura Marrone,1 Henry Duewel,2 Michael Beecroft,1 Jennifer McCourt,1
and Thammaiah Viswanatha1,3
Received December 17, 1999
1. INTRODUCTION
Lysine:N6-hydroxylase, IucD,4 catalyzes the conver-
sion of L-lysine to its N6-hydroxy derivative, the ini-
tial event in the biosynthesis of the siderophore aer-
obactin (Gibson and Magrath, 1969; Gross et al.,
1985; de Lorenzo et al., 1987; Viswanatha et al., 1987;
Goh et al., 1989; Thariath et al., 1993a). Recently,
gene fusion strategies based on the introduction of a
hydrophilic peptide segment at the N-terminus of the
iucD gene product have led to the production of recom-
binant forms of the protein (Thariath et al., 1993a,b,
1994; Stehr et al., 1999). The apo-rlucD preparation
requires FAD and NADPH for its catalytic function
(Thariath et al., I993a,b, 1994) and is stringently spe-
cific with L-lysine serving as its preferred hydroxy-
latable substrate (Marrone et al., 1996). A study of
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4 Abbreviations: ADP, adenosine diphosphate; BSA, bovine serum
albumin; CD, circular dichroism; CPDY, carboxypeptidase Y;
DFP, diisopropylfluorophosphate; dNTP, deoxynucleotide triphos-
phate; DSC, differential scanning calorimetry; DTNB, 5,5'-dithio-
bis (2-nitrobenzoic acid); DTT, DL-dithiothreitol; EDTA, ethylene-
diamine tetraacetic acid; ESMS, electrospray mass spectrometry;
CM, molar extinction coefficient; FAD, flavin adeninc dinucleotide
(oxidized form); G-6-P, glucose-6-phosphate; GDP, guanosine
diphosphate; iucD, gene encoding for lysine:N6-hydroxylase; IucD,
lysine:N6-hydroxylase, iucD gene product; mutein, protein with
amino acid replacements or deletions; NADP+, nicotinamide ade-
nine dinucleotide phosphate (oxidized form); NADPH, nicoti-
namide adenine dinucleotide phosphate (reduced form); pAT5,
plasmid bearing riucD; PIPES, piperazine-N,N6-bis(2-ethanesul-
fonic acid); PMSF, phenylmethane sulfonyl fluoride; rIucD, re-
combinant apo form of lysine:N6-hydroxylase; Leu409ter rIucD,
rIucD A17; Leu412ter rIucD; rIucD A14; Pro415ter rIucD, rIucD
Tll ; Leu418ter rIucD, rIucD T8; SBTI, soybean trypsin inhibitior;
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis; TCA, trichloroacetic acid; TFA, trifluoroacetic acid;
TLCK, N-tosyl-L-Iysyl chloromethyl ketone; and TPCK, N-tosyl-
L-phenylalanine chloromethyl ketone.
Recombinant lysine:N6 -hydroxylase, rIucD, which is isolated as an apoenzyme, requires FAD
and NADPH for its catalytic function. rIucD preparations have been found to undergo time-
dependent loss in monooxygenase function due to aggregation from the initial tetrameric state
to a polytetrameric form(s), a process which is reversible by treatment with thiols. Ligand-in-
duced conformational changes in rIucD were assessed by monitoring its CD spectra, DSC
profile, and susceptibility to both endo- as well as exopeptidases. The first two methods in-
dicated the absence of any significant conformational change in rIucD, while the last ap-
proach revealed that FAD, and its analog ADP, can protect the protein from the deleterious
action of proteases. NADPH was partially effective and L-lysine was ineffective in this re-
gard. Deletion of the C-terminal segment, either by treatment with carboxypeptidase Y or by
mutagenesis of iucD, results in the loss of rlucD's monooxygenase activity. These findings
demonstrate the crucial role of the C-terminal segment in maintaining rIucD in its native
conformation.
KEY WORDS: Lysine monooxygenase; flavoprotein; mutagenesis; protease probes; ligand protection;
C-terminus; protein stability.
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the reactivity and the function of the cysteine
residues in rIucD revealed that three of the five
residues present are accessible to reaction with DTNB
in the native conformation of the protein. However,
under identical experimental conditions, only two,
Cys51 and Cysl58, are susceptible to alkylation by
ICH2COO. Such chemical modification of rIucD is
accompanied by a loss of its lysine:N6-hydroxylase ac-
tivity, while its ability to promote NADPH oxidation
remains unaffected. Interestingly, replacement of the
above-mentioned alkylatable cysteine residues with
alanine has no adverse effect on the protein's catalytic
functions (Marrone and Viswanatha, 1997). Thus, it
would appear that the preferential disappearance of
rIucD's monooxygenase function upon chemical mod-
ification of its cysteine residues may be a reflection of
imposition of constraint(s) on its ability to undergo
substrate-induced conformational transition(s) and/or
cofactor-induced conformational changes which are in-
herent features of enzyme-catalyzed processes. In the
case of monooxygenases, this phenomenon has been el-
egantly illustrated in studies with p-hydroxybenzoate
hydroxylase (Gatti et al., 1994) and phenol hydroxy-
lase (Enroth et al., 1998), which have been shown to
alter their flavin cofactor environment in response to
the presence of their substrates. Current investigations
concern an assessment of cofactor- and/or substrate-in-
duced conformational changes in rIucD by a study of
its susceptibility to degradation by proteases.
2. MATERIALS AND METHODS
2.1. Materials
ADP, GDP, FAD, NADP+, NADPH, G-6-P, G-
6-P dehydrogenase, DTT, mercaptoethanol, TPCK-
trypsin, TLCK chymotrypsin, and azocasein were
purchased from Sigma (St. Louis, MO); media reagents
for E. coli cultures were DIFCO products. CPDY was
obtained from Calbiotech (Copenhagen). Furylacryloyl-
Phe-Ala was obtained from Bachem Biosciences
(Philadelphia, PA). Agarose, chromatography media,
alkaline phosphatase detection kit, and goat anti-rab-
bit IgG were from Bio-Rad (Richmond, CA). Custom
primary rabbit anti rIucD antibody was from Alpha
Diagnostic International (San Antonio, TX). Pwo DNA
polymerase was obtained from Boehringer Mannheim
(Mannheim, Germany). dNTPs were purchased from
Pharmacia (Uppsala, Sweden). The details regarding
the construction of pAT5 harboring iucD encoding
for rIucD have been given (Thariath et al., 1993a).
2.2. Production of Truncated Derivatives of rIucD
Incorporation of a termination triplet, TGA or
TAA, at specific locations in iucD by site-directed mu-
tagenesis provided the approach for the generation of
truncated rIucD variants. Such site-directed mutagenesis
of iucD was achieved with the aid of a QuickChange*
mutagenesis kit obtained from Stratagene cloning sys-
tem (La Jolla, CA) employing protocols recommended
by the supplier (Instruction Manual, Catalog #200518;
Revision #25001). The resourcefulness of this procedure
in achieving replacement of cysteine residues of rIucD
has recently been reported from our laboratory (Marrone
and Viswanatha, 1997). The nucleotide sequences of
mutagenic, complementary primers employed for site-
directed mutagenesis of iucD are given in Table I.
The protocols observed in the introduction of the
desired mutations in iucD by PCR are similar to those
reported previously from this laboratory (Marrone and
Viswanatha, 1997). The PCR product, following treat-
ment with DpnI to degrade the parent plasmid, was
used to transform E. coli (DH5a) and the transfor-
mants were selected on the basis of ampicillin resist-
ance. The preparation and purification of the plasmid
from these transformed cells was achieved by the al-
kali extraction method (Birnboim and Doly, 1979)
using protocols outlined in Qiagen Plasmid Handbook
(Chatsworth, CA). The successful incorporation of the
mutation was assessed by the determination of the nu-
cleotide sequence of iucD in the plasmid preparation
with the aid of the following primers:
1. M13/pUC sequencing primer (=20) (17-mer)
5'-d(GTAAAACGACGGCCAGT)-3'
2. 5 ' - d ( C C G C A A T A T C T G C C T T G G ) - 3 '
(426-443) (18-mer)
3. 5'-d (GGAAAGTAGTGGTCCTGG)-3' (900-
917) (18-mer)
4. M13/pUC reverse sequencing primer (=24)
(16-mer), 5'-d(AACAGCTATGACCATG)-3'
The nucleotide sequence determination was per-
formed by Mobix Central Core Facility, McMaster
University, Hamilton, Ontario, Canada, employing
the dideoxynucleotide method (Sanger et al., 1977).
2.3. Synthesis and Purification of the Decapeptide
(C-Peptide)
The decapeptide Pro-Ala-Leu-Ile-Gln-Trp-Arg-
Ser-Gly-(D)-Thr, with the amino acid sequence corre-
sponding to that of the C-terminal segment (residues
416-425) of rIucD except for a change in the configu-
ration of the terminal threonine residue, was synthe-
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sized by Dr. B. A. K. Chibber (Central Bio-core Facil-
ities, University of Notre Dame, Notre Dame, IN). The
material was purified by HPLC on a 0.8 x 10 cm Bon-
dapak C18 RCM column employing a solvent system
comprising water (0.1% TFA) and CH3CN (0.1%
TFA), with the latter being brought to 25% and 90%
after 40 and 50 min, respectively, of the initiation of
the procedure (flow rate, 1 ml/min; temperature,
25°C). The material was characterized by ESMS
analysis. Calculated: 1128.3; found, 1127.4.
2.4. Isolation and Purification of rIucD and Muteins
The isolation and purification of rIucD and its
muteins was achieved according to the procedures
documented earlier (Thariath et al., 1993a; Marrone
and Viswanatha, 1997).
2.5. Determination of Protein and DNA
Concentration
The concentration of rIucD was determined spec-
trophotometrically using an eM value of 6.2 x 10
4 M–1
cm–1 (Marrone and Viswanatha, 1997). Concentrations
of DNA (plasmid or primer) were determined from the
absorbance at 260 nm as follows: one absorbance unit
corresponds to 50 and 38 mg/ml of the double-stranded
(plasmid) and single-stranded (mutagenic primers)
DNA, respectively (Sambrook et al., 1989).
2.6. Determination of Lysine :N6-Hydroxylase
Activity
The protocol employed for the measurement of ly-
sine:N6-hydroxylase activity was similar to that re-
ported previously (Parniak et al., 1979). A typical
assay, in a final volume of 5 ml, consisted of potassium
phosphate (100 mM, pH 7.2), L-lysine (1 mM), FAD
(40 mM), and rIucD (83.3 nM). The reaction was initi-
ated by the introduction of an NADPH-generating sys-
tem comprising NADP+ (80 mM), glucose-6-phosphate
(1 mM), and glucose-6-phosphate dehydrogenase
(1.25 units) preincubated at 37°C for 5 min. Following
incubation at 37°C for 15 min, the reaction was termi-
nated by the addition of a slurry of Dowex 50W-X8
(200–400 mesh, H+ form) resin in distilled water. The
entire mixture was transferred to a 1.4 x 25-cm glass
column and washed with 0.2 M HC1 (40 ml) prior to
elution with 6 M HC1 (25 ml). The effluent was taken
to dryness and the residue was dissolved in water and
used for the determination of N6-hydroxylysine by the
iodine oxidation procedure (Tomlinson et al., 1971).
2.7. Proteolysis of rIucD
The influence of various ligands on rIucD's sus-
ceptibility to degradation by proteases was investi-
gated both by an assessment of change(s) in its struc-
tural integrity by SDS–PAGE as well as in its ability
to function as lysine monooxygenase. In these studies
TPCK-trypsin, TLCK-chymotrypsin, and thermolysin
served as representatives of endopeptidases, while
carboxypeptidase Y served as an exopeptidase. The
conditions chosen were such as to allow for the main-
tenance of rIucD in its native conformation and yet
permit its rapid degradation upon treatment with the
protease.
In the experiments with endopeptidases, the pro-
tocol employed was as follows: rIucD (10–14 mM) in
100 mM potassium phosphate, pH 7.0 (or 100 mM
PIPES, pH 7.5, containing 10 mM CaCl2, in the case
of thermolysin), and endoprotease (5–7 mM); temper-
ature, 25°C. Aliqouts were drawn at desired intervals

































a The plasmid pAT5 (Thariath et al., 1993a) was used to effect deletion at the desired location. The incorporation of the termination triplet at
the desired location was achieved by the use of complimentary primers (1) and (2) containing the deletion codon (underlined).
896 Dick et al.
and proteolysis was terminated by the addition of
appropriate inhibitor (twofold excess of SBTI for
TPCK-trypsin, 10 mM PMSF for TLCK-chy-
motrypsin, and 10 mM EDTA for thermolysin) prior
to use for SDS-PAGE and determination of ly-
sine:N6-hydroxylase activity.
In the case of CPDY, a typical reaction mixture,
in a final volume of 1 ml, comprised potassium phos-
phate (100 mM, pH 6.0), rIucD (10 UM), and CPDY
(0.3 UM). The reaction was allowed to proceed at
37°C. Aliquots drawn at desired intervals were either
diluted (1:1000) with phosphate buffer (pH 7.0) or
with 200 mM tris-glycine (pH 8.3). The former sample
was used for the determination of lysine:N6-hydroxylase
activity and the latter for SDS-PAGE analysis.
The final concentration of the cofactor or the sub-
strate, when included, was as follows: FAD (0.5-1 mM),
ADP (1 mM), NADPH (1 mM), and L-lysine (5 mM).
For the quantitative estimation of the amino acids
released by action of exopeptidases, the procedure was
similar to that documented previously (Martin et al.,
1977). Aliquots drawn at desired intervals were treated
with a slurry of Dowex 50-X16 (H+ form resin). The
resin was washed extensively with water and the
amino acids were recovered by elution with 6 N HC1.
After removal of HC1, the sample was analyzed for
amino acids by ion exchange chromatography (Spack-
man et al., 1954).
In some experiments, the C-peptide (see Section
2.3 for details of the peptide preparation) was included
in the reaction mixture over a concentration range of
0.1-0.5 mM.
2.8. Influence of FAD and ADP on the Catalytic
Activity of Proteases
The effect of ADP and FAD on the proteolytic
activity of endopeptidases (TPCK-trypsin, TLCK-
chymotrypsin, and thermolysin) was assessed using
azocasein as the substrate (Cowan and Daniel, 1982).
A typical reaction, in a final volume of 3 ml, consisted
of azocasein (1% w/v), potassium phosphate (100 mM,
pH 7.5), and endopeptidase (150 Ug). FAD and ADP
when included were used at a final concentration of
1 mM. Following incubation at 25°C for 30 min, the
reaction was terminated by the addition of an equal
volume of TCA (10%). After 1 hr of standing at room
temperature, the suspension was centrifuged and the
extent of proteolysis was determined by measurement
of the absorbance at 336 nm of the supernatant.
The enzymatic activity of CPDY was assessed
using furyl acryloyl-L-Phe-L-Ala (FA-Phe-Ala) as
substrate (Breddam, 1986). Typically, the reaction
mixture, 1 ml in volume, consisted of potassium phos-
phate (100 mM, pH 6.0), FA-Phe-Ala (0.5-1.0 mM),
and CPDY (10 Ug). The assay, initiated by the addition
of CPDY, was followed by monitoring the decrease in
absorbance at 340 nm. When included in the experi-
ment, the concentration of ADP or FAD was 1 mM.
The concentration of the C-peptide was varied
over the range 0.06-0.5 mM in the experiments de-
signed to assess its effect on the catalytic activity of
CPDY.
2.9. SDS-PAGE and Western Blot Analysis
SDS-PAGE analyses of rIucD and its variants at
various stages of their purification were performed
using 10% polyacrylamide gels according to the pro-
cedure of Laemmli (1970).
Whole-cell lysates were also examined for the
presence of the iucD gene product and these were pre-
pared by suspension of cells, collected by centrifuga-
tion after 24 hr of growth, in SDS-PAGE sample
buffer and boiled for 3 min.
For Western blot analysis, protein samples (25 Ug
protein), after separation by SDS-PAGE (12% gel),
were transferred to nitrocellulose over 2 hr at 4°C fol-
lowed by two brief washes in Tris-buffered saline
(TBS; 20 mM Tris, 500 mM NaCl, pH 7.5). Nonspe-
cific binding of the antibody was inhibited by blocking
the membrane with 5% (w/v) low-fat milk powder in
TBS overnight at 4°C. The membrane was then rinsed
twice with TTBS (TBS containing 0.05% Tween-20)
for 5 min prior to incubation with purified polyclonal
rabbit anti-rIucD (1:2000 dilution in TTBS) for 2 hr at
room temperature. The membrane was rinsed twice in
TTBS for 10 min at room temperature prior to incuba-
tion with goat anti-rabbit alkaline phosphatase conju-
gated secondary antibody (1:3030 dilution in TTBS)
for 2 hr at room temperature. The membrane was sub-
sequently washed twice for 5 min in TTBS and once in
TBS for 5 min prior to detection by incubation with
nitroblue tetrazolium and bromochloroindolyl phosphate
(Blake et al., 1984).
2.10. CD
CD spectra were recorded over the range 185- 250
nm on a Jasco J-700 Spectropolarimeter set at 20 mdeg
sensitivity, 0.2 nm resolution, four unit accumulation,
8 sec response, and a scanning speed of 200 nm/min.
The rIucD concentration was 5-15 UM in 200 mM
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potassium phosphate, pH 7.0. Measurements were made
in a 300-U1 cylindrical quartz cell with a 1 mm path-
length. Concentrations of ligands when used were FAD
(200 UM), ADP (1 mM), and L-lysine (5 mM). All
spectra were corrected for the appropriate blank solu-
tions, recorded in the absence of enzyme. Each spec-
trum is the average of three scans. [O]mr, the mean
residue elipticity, is calculated using the following
equation:
where / is the pathlength in cm, c is the molar concen-
tration of the protein, n is the number of residues in the
protein, and CD is the observable value.
2.11. DSC
Differential scanning calorimetric studies were
performed using a Nano DSC from Calorimetry Sci-
ences Corp. (Provo, UT). The rIucD concentration was
1 mg/ml in 200 mM potassium phosphate, pH 7.0, con-
taining DTT (1 mM). Concentrations of ligands when
present were FAD (0.5 mM), ADP (1 mM), and L-lysine
(5 mM). Heating rate was 1 deg/min.
3. RESULTS
3.1. Stability of rIucD in the Absence of Cofactors
and Substrate
Apo-rIucD preparations have been shown to
undergo facile denaturation in media of low ionic
strength. As a consequence, protein preparations are
routinely maintained in media of ionic strength >0.25
and under these conditions rIucD exists in a tetrameric
form with a molecular weight of approximately 200 kDa
(Thariath et al., 1993a,b, 1994). SDS-PAGE analyses
of rIucD immediately after its isolation, under non-
reducing conditions, have revealed the protein to mi-
grate as a single component with a molecular weight
(-50 kDa) corresponding to that of the monomer, indi-
cating the absence of intersubunit disulfide bridges in
its tetrameric structure. Storage of rIucD, either at 4°C
or -80°C, under conditions that minimize its denat-
uration (potassium phosphate, pH 7.0, ionic strength
-0.25) has been found to be accompanied by a pro-
gressive loss in its monooxygenase activity. This phe-
nomenon could be reversed with complete restoration
of monooxygenase function by treatment with thiol
reagents such as DTT (>10 mM), indicating participa-
tion of the protein's cysteine residues in the formation
of disulfide bridges during its storage. In order to as-
sess whether these disulfide bridges occur within the
tetramer (intratetramer) or between tetramers (inter-
tetramer) of rIucD, the molecular weight of the protein
was monitored by chromatography on Superdex 200
matrix at various intervals subsequent to its isolation.
These studies have revealed that rIucD, immediately
after isolation, exists predominantly as a tetramer
(Fig. 1A). During storage, this form of the protein dis-
appears with the concomitant appearance of species
with molecular weights >200 kDa (Fig. IB). Treatment
of such protein preparations with DTT results in the
restoration of the initial tetrameric state (Figs. 1C and
1D), indicating a rupture of intertetrameric disulfide
bridges by the thiol reagent. As noted above, DTT
treatment is also accompanied by restoration of the
monooxygenase function of the protein. However, it is
not possible to attribute the regeneration of enzymatic
activity solely to the rupture of intertetramer disulfide
bridges, since similar linkages occurring either within or
between the monomeric subunits contributing to the
tetrameric structure of the protein are also prone to
reduction by the thiol reagents.
3.2. Interaction of rIucD with Its Ligands
The conformational changes in rIucD accompany-
ing its interaction with its ligands were assessed by ex-
amining the CD spectra, DSC profiles of the protein,
and its susceptibility to degradation by proteases. Nei-
ther the CD spectra nor the DSC profile of rIucD was
significantly affected in the presence of its cofactors or
substrate (Figs. 2 and 3). However, its susceptibility to
the action of proteases was found to be influenced by
the presence of some of its ligands; the details are given
below.
Treatment of rIucD with TPCK-trypsin (see Sec-
tion 2 for details) resulted in its rapid degradation of
the protein with concomitant loss of its monooxyge-
nase activity. Similar studies performed in the pres-
ence of FAD (0.5 mM) revealed the absence of such
adverse action by the protease as indicated by the total
retention of rIucD's structural integrity and catalytic
function. Further investigations performed over a
range of FAD concentrations indicated that a cofactor
concentration of 200 UM was adequate to protect
rIucD from proteolytic degradation. Interestingly,
ADP (1 mM) was also found to shield rIucD from
tryptic digestion as indicated by the preservation of the
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Fig. 2. CD spectra of rIucD. Solid line, no ligands; dashed line, lysine
(1 mM); dashed and dotted line, lysine (1 mM) and FAD (200 UM).
Fig. 1. Superdex 200 chromatography of rIucD preparations. The
conversion of the tetrameric form of rIucD to polytetrameric species
and the reversal of this process by DTT was monitored by
chromatography of the samples on a 10 mm x 30 cm Superdex 200
column with 100 mM potassium phosphate, pH 7.0, serving both as
equilibration and elution medium. Prior to chromatography of rIucD
samples, calibration was achieved by the determination of the
retention times of molecular weight standards as follows: cytochrome
c (12.4 kDa), 17.6 min; carbonic anhydrase (30 kDa), 16.5 min;
albumin (67 kDa), 14.1 min; alcohol dehydrogenase (128 kDa),
12.8 min; and B-amylase (200 kDa), 12.2 min. Under these conditions,
freshly prepared rIucD was found to have a retention time of
12.4 min. Experimental conditions: protein concentration as shown;
eluant, 100 mM potassium phosphate, pH 7.0; flow rate, 1 ml/min;
chart speed, 0.4 cm/min. (A) rIucD immediately after isolation from
protein's structural integrity and catalytic function. Of
the other two obligatory participants in the catalytic
process mediated by rIucD, NADPH and L-lysine, the
former was partially effective, while the latter (5 mM)
was totally ineffective in preventing the protein from
degradation by trypsin. Thus, in the presence of
NADPH (1 mM), approximately 50% rIucD was de-
graded by the protease as indicated by SDS-PAGE
analysis and measurement of lysine:N6-hydroxylase
activity. These results are presented in Fig. 4.
In the experiments with TLCK-chymotrypsin and
thermolysin, the observations were similar to those
recorded in the studies with TPCK-trypsin. Both FAD
and ADP prevented rIucD degradation by these pro-
teases, while NADPH and lysine were marginally ef-
fective and ineffective respectively (data not shown).
chromatography on Orange A Dye matrix (Thariath et al., 1993a),
50 Ul (8 Ug) of sample was injected; (B) rIucD sample from storage
at -80°C, allowed to thaw at 4°C for 24 h (free of NaCl and DTT);
25 Ul (34 Ug) of sample was injected; (C) rIucD, same as in B, but
for treatment with DTT (10 mM) for 75 min; 25 Ul of sample was
injected; (D) rIucD, same as in B, but for treatment with DTT (50
mM) for 180 min; 25 U1 of sample was injected. Species emerging
at 12.4 min represents the rIucD tetramer; species emerging at
times <12.4 min reflect the polytetrameric form(s) of rIucD; and
the species emerging at times >12.4 min represent buffer ions
and/or DTT.
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Fig. 3. DSC profile of rIucD. Solid line, no ligands; dashed line,
ADP (1 mM); dotted line, FAD (0.5 mM); dashed and dotted line,
lysine (5 mM).
The protective effect exerted by FAD and ADP does
not appear to be due to their ability to function as in-
hibitors of the proteases since these compounds have
no adverse effect in experiments with azocasein serv-
ing as a substrate.
The reaction of rIucD with CPDY was accom-
panied by a steady decline in lysine:N6-hydroxylase
activity with approximately 85% activity being lost
after 80 min of incubation (Fig. 5). At this stage of the
reaction with CPDY, analyses revealed the release of
the following C-terminal amino acids residues from
rIucD (amounts relative to that of threonine in paren-
theses): Thr (1.00), Ser (1.20), Gly (1.80), Arg (0.91),
Glu (0.25), Ile (0.80), Leu (0.96), Ala (1.10), and Pro
(1.20). Allowing for the loss of tryptophan under
strong acidic conditions and the low recovery of glu-
tamic acid, due to its poor retention by the cation ex-
change resin (in view of the relatively high ionic
strength of the CPDY reaction medium), the above data
would appear to be consistent with the deletion of
10-11 C-terminal amino acid residues from rIucD. In-
terestingly, both FAD (1 mM) and ADP (1 mM) of-
fered protection from such deleterious effects as indi-
cated by total retention of rIucD's monooxygenase
activity even after prolonged exposure to CPDY, while
NADPH and lysine were devoid of such beneficial ac-
tion (Table II). Finally, FAD and ADP were found to
have no adverse effect on the ability of CPDY to me-
diate the hydrolysis of its typical peptide substrate,
furylacryloyl–Phe–Ala. Hence, their protective influ-
ence observed in the studies with rIucD would appear
to be due to factors other than functioning as inhibitors
of the exoprotease.
Fig. 4. (A) SDS–PAGE profile of rIucD samples treated with TPCK-
trypsin. rIucD (14 UM) was incubated (25°C, 12 min) with TPCK-
trypsin (7 nM) in the presence of cofactors and substrate indicated.
The reaction was stopped by the addition of SBTI (15 UM) prior to
analysis. Lanes: 1, FAD (0.5 mM); 2, ADP (1.0 mM); 3, NADPH (1.0
mM); 4 L-lysine (5 mM); 5, L-norleucine (1 mM); 6, none; 7, control,
trypsin added after SBTI; 8, molecular weight standards expressed in
kDa (phosphorylase b, 94; serum albumin, 67; ovalbumin, 43;
carbonic anhydrase, 30; trypsin inhibitor, 20; and a-lactalbumin, 14).
(B) Vertical bar graph representation of lysine:N6-hydroxlyase
activity following treatment with TPCK-trypsin. Lysine:N6-
hydroxlyase activity was determined after addition of SBTI as
mentioned above in A. The vertical bars are matched to their
corresponding lanes in A. Increase in NADPH concentration has been
found to result in an enhanced protection from degradation by the
protease, with maximum value (-80%) being achieved at an NADPH
concentration of 7 mM (data not shown). Studies with azocasein as
substrate revealed that none of the cofactors, even at the highest
concentrations, function as inhibitors of the proteases.
The deletion of the C-terminal residues of rIucD
would appear to result in a disruption of its native
conformation as indicated by the development of
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Fig. S. Effect of CPDY on lysine:N6-hydroxylase activity of rIucD.
rIucD (10 UM) in 100 mM potassium phosphate, pH 6.0, was treated
with CPDY (20 Ug) at 37°C. The concentration of other compounds,
when included, were FAD (0.5 mM) and ADP (1.0 mM). Aliquots
taken at desired intervals were diluted (1:1000) with 200 mM
potassium phosphate buffer, pH 7.0, to stop further degradation and
used for the determination of lysine:N6-hydroxylase activity.(D-D)
none;(R-R) control (no CPDY); (T-T)FAD or ADP. L-Lysine (5 mM)
failed to protect from the adverse action of CPDY (data not shown).
Table II. Susceptibility of rIucD to Degradation by Proteases:
































a In the case of TPCK-trypsin and TLCK-chymotrypsin, rIucD
(12-14 UM) in 100 mM potassium phosphate, pH 7.0, was treated
with the protease (6-7 UM) at 25°C. After 12 min, the reaction was
stopped by the addition of SBTI or PMSF prior to determination of
lysine:N6-hydroxylase activity. In the case of CPDY, rIucD (10
UM) in 100 mM potassium phosphate, pH 6.0, was treated with the
exopeptidase (0.3 UM) for 2 hr at 37°C prior to determination of
lysine: N6-hydroxylase activity. The concentration of effector,
when included, is as shown in the table. Similar results were ob-
tained with thermolysin (data not shown).
opalescence in the reaction mixture(s) after prolonged
(>75 min) incubation with the exoprotease. Since
these observations suggested a crucial role for the C-
terminal segment in the maintenance of rIucD in its
native conformation, the possibility of synthetic pep-
tide mimic(s) compensating for the section deleted by
CPDY was explored by performing experiments in the
presence of the C-peptide (Pro-Ala-Leu-Ile-Gln-Trp-
Arg-Ser-Gry-(D)-Thr; see Section 2 for details). These
studies showed that in the presence of the C-peptide
(0.5 mM), rIucD's monooxygenase activity remained
unaffected even after prolonged (> 3 hr) period of reac-
tion with CPDY. Hence, the following three aspects
were considered to explain the protective influence ex-
erted by the C-peptide: (i) its ability to compensate for
the section of the protein deleted by CPDY; (ii) the pos-
sibility of its competing with rIucD and serving as a
substrate for CPDY; and (iii) its capacity to serve as an
inhibitor of CPDY. The first of these three aspects
would appear untenable, since addition of C-peptide to
rIucD preparations pretreated with the CPDY did not re-
sult in the restoration of lysine monooxygenase activity.
Concerning the second aspect, HPLC analysis of the
C-peptide preparation subsequent to its treatment with
CPDY indicated the absence of any degradation, point-
ing to its inability to serve as a substrate for the exo-
protease. This finding is not unexpected in view of the
D-configuration of the C-peptide's carboxy terminal
residue, a feature deliberately incorporated to minimize
its serving as a substrate for CPDY. The ability of the
C-peptide to act as an inhibitor of CPDY was confirmed
in the studies using furylacryloyl-Phe-Ala. Data shown
in Fig. 6 show that the C-peptide is an effective inhibitor
of CPDY, with approximately 90% inhibition in the
hydrolysis of the chromophoric peptide substrate being
noted when it is present at a concentration of 90 UM.
3.3. Studies with C-Terminal-Truncated Forms
of rIucD
In order to gain unambiguous insight into struc-
tural feature(s) indispensable for the maintenance of
Fig. 6. CPDY-catalyzed hydrolysis of furylacryloyl-Phe-Ala. Con-
ditions: FA-Phe-Ala (1 mM) in 100 mM potassium phosphate, pH
6.0, with CPDY (10 Ug). (1) In the absence of C-peptide; (2) in the
presence of C-peptide (90 UM).
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rIucD in its native conformation, four well-defined
rIucD variants, differing in the extent of C-terminal
deletions, were developed (Table I). The ability of
truncated versions of iucD to encode for a catalytically
functional protein was assessed by examining the cul-
ture fluids for the presence of N6-hydroxylysine, an in-
herent feature of cells expressing the catalytically func-
tional form of rIucD. Such analyses revealed the
presence of N6-hydroxylysine only in the culture fluid
of cells designed to express rIucD A8 and not in the
case of cells transformed to express the other three
truncated iucD gene products, namely rIucD T17,
rIucD T14, and rIucD Tll. The absence of N6-hydrox-
ylysine in the case of the latter three cultures could be
either due to their inability to express these particular
truncated forms of iucD or a reflection of a loss of cat-
alytic function in the three truncated forms of rIucD.
Analyses of the whole-cell lysates of cultures express-
ing these truncated proteins revealed the presence, in
all four cases, of a protein with a molecular weight cor-
responding to that of the iucD gene product, and its
identity as such was further confirmed by Western blot
analyses using polyclonal antibodies raised against
rlucD (Fig. 7). Thus, all four truncated forms of the
iucD gene product would appear to be expressed. How-
ever, while rIucD T8 is capable of lysine N-hydroxyla-
tion, the other three muteins (rIucD T17, rIucD A14,
and rlucD Tll) are devoid of such catalytic activity.
Furthermore, during attempts to isolate these truncated
rIucD preparations, it was noted that their presence
could be detected only in the whole-cell lystates and
the crude cell-free systems, but not in the fractions ob-
tained in subsequent stages of purification. This find-
ing is in distinct contrast with those noted in the case
of normal rIucD, which is detectable during all stages
of purification (Thariath et al., 1993a, b, 1994): The la-
bility of these truncated rIucD preparations during later
stages of purification would appear to be related to the
removal of flavin cofactor(s) normally associated with
whole cells and the crude cell-free system. This obser-
vation is consistent with the protective action of FAD
mentioned in the previous section.
Fig. 7. Western blot analyses. The expression of truncated forms
of rIucD in E. coli DH5a and their stability during the protocol for
their purification was monitored by Western blot analyses using
polyclonal rabbit anti-rIucD antibodies (see Section 2 for details).
Results obtained with rIucD T17 are typical of those recorded with
other truncated rIucD preparations. Similar studies with intact
rIucD served as a control. (A) Western blot identification of rIucD,
from left to right: (i) whole-cell lysate, (ii) crude cell-free extract, (iii)
ammonium sulfate (40%) fraction, and (iv) pure rIucD. (B) Western
4. DISCUSSION
The observations recorded in this study have re-
vealed that neither the substrate (L-lysine) nor the co-
blot identification of rIucD T17, from left to right: (i) whole-cell
lysate, (ii) cell-free extract, and (iii) ammonium sulfate (40%)
precipitate.
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factor (FAD) elicits significant conformational changes
in rIucD as is evident from the CD and DSC profiles
(Figs. 2 and 3). However, when susceptibility to degra-
dation by proteases is employed as a criterion for mon-
itoring the structural changes in rIucD, significant dif-
ferences in the response due to interaction with its
various ligands become apparent. Thus, rIucD, in the
absence of its cofactors or substrate, is susceptible to
degradation both by endopeptidases as well as an ex-
opeptidase (CPDY) with concomitant loss of its mono-
oxygenase function. Such adverse action of proteases
on rIucD is completely prevented when experiments
are performed in the presence of low concentrations of
FAD (0.2 mM) or ADP (0.5 mM). Concerning the
other two ligands, NADPH (1 mM) has been found to
confer partial protection, while the substrate, L-lysine
(5 mM), is virtually ineffective in preventing the pro-
teolytic degradation of rIucD. The reasons for the in-
ability of L-lysine, the preferred substrate, to protect
rIucD from the deleterious action of proteases are not
clear. In the case of the flavin cofactor, the magnitude
of the dissociation constant KD of the rIucD-ligand
complex would appear to govern their effectiveness in
rendering the protein resistant to the action of pro-
teases. Thus, since rIucD's interaction with FAD is
characterized by a KD value of approximately 20 UM
(Marrone, 1997), cofactor concentrations (>200 UM)
that ensure the maintenance of the protein in the ligand
bound, or the holoenzyme, state are effective in pro
tecting it from proteolytic degradation. The ability of
ADP to bind at the flavin cofactor site (Marrone, 1997)
appears to be responsible for its protective effect.
Under conditions identical with those employed
in the studies with FAD, NADPH (1 mM) has been
found to be only partially effective in preventing the
proteolysis of rIucD as indicated by the retention of
-50% of the protein's monooxygenase activity (Fig. 4).
Further increases in the concentration of NADPH
result in an enhancement in the degree of protection
afforded to rIucD, with a maximum value, -80% re-
tention of monooxygenase activity, being observed at
cofactor concentrations >7 mM (data not shown). The
reasons for not achieving complete protection are not
obvious. The finding may be a reflection of a high KD
value of the rIucD-NADPH complex. Although an ap-
parent KM value of approximately 100 (AM for the re-
duced pyridine nucleotide cofactor has been recorded
in experiments with lysine:N6-hydroxylase activity
serving as the criterion for the assessment (Thariath
et al., 1993b, 1994), efforts to determine the actual KD
value of the rIucD:NADPH complex have been futile.
It is not clear whether this situation is a reflection of
the protein's binding of NADPH being contingent
upon its initial interaction with FAD. The situation ap-
pears to be similar to that recorded in the case of p-
hydroxybenzoate hydroxylase, which also utilizes FAD
and NADPH as cofactors. In the case of this latter en-
zyme, X-ray crystallographic studies have not been suc-
cessful in identifying the NADPH-binding domain, in
view of the cofactor's propensity to displace FAD from
its binding domain in the protein (van der Laan et al.,
1989). These observations pertaining to the protection
of rIucD by ligands are analogous to those recorded in
the case of glucose oxidase (Swoboda, 1969), creatine
kinase (Jacobs and Cunningham, 1968), and NADPH-
quinone reductase (Chen et al., 1994).
Both the studies with CPDY as well as those with
well-defined C-terminal deletion variants of rIucD
have provided unambiguous evidence for the indis-
pensability of the C-terminal segment for rIucD to
function as a monooxygenase. The latter approach has
also resulted in pinpointing the segment essential for
the protein to be catalytically functional. Thus, while
rIucD All is incapable of N6-hydroxylysine produc-
tion, the rIucD A8 variant is competent to perform
such a function. This observation suggests that the
structural feature(s) inherent in this segment, residues
415-417, may be crucial for the maintenance of rIucD
in its catalytically active conformation.
Reports concerning the importance of the C-ter-
minal domain for the structural integrity and/or catalytic
function of proteins have been widely documented (Yu
et al., 1998; Dai and Wang, 1997; Albalat et al., 1995;
Walter et al., 1999; Nechushtan et al., 1999; Shimada
et al., 1999; Criado et al., 1999; Mata et al., 1999; Al-
lardyce et al., 1999). The observations recorded in the
case of lipoamide dehydrogenase from Azotobacter
vinelandii would appear to be especially relevant since
this protein, like rIucD, is both oligomeric and utilizes
FAD for its catalytic function (Mattevi et al., 1991).
The function of the C-terminus of this protein has been
investigated by deletion of 5, 9, and 14 C-terminal
residues respectively. Deletion of 5 residues had no
adverse effects, that of 9 residues led to decreased con-
formational stability, and the removal of 14 residues
was accompanied by complete loss of catalytic func-
tion (Benen et al., 1992). Furthermore, these studies
also demonstrated the presence of intersubunit inter-
action involving a tyrosine residue at the N-terminus
of one subunit and a histidine at the C-terminus of the
second subunit. This structural feature, which is pro-
posed to be involved in mediating the redox properties
of the flavin cofactor via the conformation of the C-
terminal segment, is not present in preparations of en-
Lysine: N6-Hydroxylase 903
zyme with deletion of either 9 or 14 C-terminal residues
(Benen et al., 1992). Further studies are needed, espe-
cially the elucidation of the three-dimensional structure
of the protein, to determine whether a similar situation
as above prevails in rIucD.
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